JP2014523521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014523521A5 JP2014523521A5 JP2014513770A JP2014513770A JP2014523521A5 JP 2014523521 A5 JP2014523521 A5 JP 2014523521A5 JP 2014513770 A JP2014513770 A JP 2014513770A JP 2014513770 A JP2014513770 A JP 2014513770A JP 2014523521 A5 JP2014523521 A5 JP 2014523521A5
- Authority
- JP
- Japan
- Prior art keywords
- loxl2
- disease
- antibody
- level
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161492210P | 2011-06-01 | 2011-06-01 | |
| US61/492,210 | 2011-06-01 | ||
| US201161550895P | 2011-10-24 | 2011-10-24 | |
| US61/550,895 | 2011-10-24 | ||
| US201161578813P | 2011-12-21 | 2011-12-21 | |
| US61/578,813 | 2011-12-21 | ||
| PCT/US2012/040585 WO2012167181A1 (en) | 2011-06-01 | 2012-06-01 | Lysyl oxidase-like 2 assay and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016115175A Division JP2016164578A (ja) | 2011-06-01 | 2016-06-09 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014523521A JP2014523521A (ja) | 2014-09-11 |
| JP2014523521A5 true JP2014523521A5 (enExample) | 2015-06-18 |
Family
ID=46208194
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014513770A Withdrawn JP2014523521A (ja) | 2011-06-01 | 2012-06-01 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
| JP2016115175A Pending JP2016164578A (ja) | 2011-06-01 | 2016-06-09 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
| JP2017221000A Pending JP2018049033A (ja) | 2011-06-01 | 2017-11-16 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016115175A Pending JP2016164578A (ja) | 2011-06-01 | 2016-06-09 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
| JP2017221000A Pending JP2018049033A (ja) | 2011-06-01 | 2017-11-16 | リシルオキシダーゼ様２のアッセイおよびその使用の方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20140206017A1 (enExample) |
| EP (1) | EP2714744A1 (enExample) |
| JP (3) | JP2014523521A (enExample) |
| KR (1) | KR20140048156A (enExample) |
| CN (1) | CN103946241A (enExample) |
| AP (1) | AP2013007285A0 (enExample) |
| AR (1) | AR086657A1 (enExample) |
| AU (2) | AU2012261883A1 (enExample) |
| BR (1) | BR112013030682A2 (enExample) |
| CA (1) | CA2837534A1 (enExample) |
| CL (1) | CL2013003445A1 (enExample) |
| CO (1) | CO6940375A2 (enExample) |
| CR (1) | CR20130657A (enExample) |
| EA (1) | EA201391627A1 (enExample) |
| EC (1) | ECSP13013092A (enExample) |
| IL (1) | IL229631A0 (enExample) |
| MA (1) | MA35212B1 (enExample) |
| MD (1) | MD20130098A2 (enExample) |
| MX (1) | MX2013013905A (enExample) |
| PE (1) | PE20141450A1 (enExample) |
| PH (1) | PH12013502490A1 (enExample) |
| TW (1) | TW201319572A (enExample) |
| UY (1) | UY34115A (enExample) |
| WO (1) | WO2012167181A1 (enExample) |
| ZA (1) | ZA201308812B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| CN110372795A (zh) | 2007-08-02 | 2019-10-25 | 吉利德生物制剂公司 | Lox和loxl2抑制剂及其应用 |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| RU2012110585A (ru) | 2009-08-21 | 2013-09-27 | Джилид Байолоджикс, Инк. | Каталичические домены лизилоксидазы и loxl2 |
| RU2015108348A (ru) | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения |
| SG11201503065PA (en) * | 2012-10-30 | 2015-05-28 | Gilead Sciences Inc | Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2) |
| US20150342943A1 (en) | 2014-06-03 | 2015-12-03 | Gilead Sciences, Inc. | Methods of treating liver disease |
| SG11201609522TA (en) * | 2014-06-11 | 2016-12-29 | Gilead Sciences Inc | Methods for treating cardiovascular diseases |
| MA41252A (fr) | 2014-12-23 | 2017-10-31 | Gilead Sciences Inc | Formes solides d'un inhibiteur d'ask 1 |
| CA3016081A1 (en) | 2016-03-04 | 2017-09-08 | Gilead Sciences, Inc. | Compositions and combinations of autotaxin inhibitors |
| JP2019513737A (ja) | 2016-04-08 | 2019-05-30 | ギリアード サイエンシーズ， インコーポレイテッド | がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法 |
| GB201704206D0 (en) | 2017-03-16 | 2017-05-03 | Nordic Bioscience As | Lysyl oxidase like-2 assay |
| WO2023091479A1 (en) * | 2021-11-17 | 2023-05-25 | AmMax Bio, Inc. | Detection and treatment of idiopathic pulmonary fibrosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6352862B1 (en) * | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| FI92882C (fi) * | 1992-12-29 | 1995-01-10 | Medix Biochemica Ab Oy | Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi |
| US20030114410A1 (en) * | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| CN110372795A (zh) * | 2007-08-02 | 2019-10-25 | 吉利德生物制剂公司 | Lox和loxl2抑制剂及其应用 |
| JP2010038735A (ja) * | 2008-08-05 | 2010-02-18 | Terumo Corp | 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙 |
| BR112012008080A2 (pt) * | 2009-08-21 | 2017-07-04 | Gilead Biologics Inc | ensaios de rastreamento in vivo. |
| RU2015108348A (ru) * | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения |
| US9556882B2 (en) * | 2011-05-10 | 2017-01-31 | Borgwarner Inc. | Turbocharger with variable turbine geometry |
-
2012
- 2012-06-01 US US14/122,984 patent/US20140206017A1/en not_active Abandoned
- 2012-06-01 US US13/487,109 patent/US20120309020A1/en not_active Abandoned
- 2012-06-01 MX MX2013013905A patent/MX2013013905A/es not_active Application Discontinuation
- 2012-06-01 WO PCT/US2012/040585 patent/WO2012167181A1/en not_active Ceased
- 2012-06-01 AP AP2013007285A patent/AP2013007285A0/xx unknown
- 2012-06-01 EA EA201391627A patent/EA201391627A1/ru unknown
- 2012-06-01 BR BR112013030682A patent/BR112013030682A2/pt not_active IP Right Cessation
- 2012-06-01 CN CN201280037235.7A patent/CN103946241A/zh active Pending
- 2012-06-01 JP JP2014513770A patent/JP2014523521A/ja not_active Withdrawn
- 2012-06-01 UY UY0001034115A patent/UY34115A/es not_active Application Discontinuation
- 2012-06-01 MD MDA20130098A patent/MD20130098A2/ro not_active Application Discontinuation
- 2012-06-01 PE PE2013002739A patent/PE20141450A1/es not_active Application Discontinuation
- 2012-06-01 TW TW101119847A patent/TW201319572A/zh unknown
- 2012-06-01 KR KR1020137034711A patent/KR20140048156A/ko not_active Withdrawn
- 2012-06-01 CA CA2837534A patent/CA2837534A1/en not_active Abandoned
- 2012-06-01 AU AU2012261883A patent/AU2012261883A1/en not_active Abandoned
- 2012-06-01 EP EP12725601.4A patent/EP2714744A1/en not_active Withdrawn
- 2012-06-01 PH PH1/2013/502490A patent/PH12013502490A1/en unknown
- 2012-06-01 AR ARP120101959A patent/AR086657A1/es unknown
-
2013
- 2013-11-25 ZA ZA2013/08812A patent/ZA201308812B/en unknown
- 2013-11-26 IL IL229631A patent/IL229631A0/en unknown
- 2013-11-29 CL CL2013003445A patent/CL2013003445A1/es unknown
- 2013-12-13 CR CR20130657A patent/CR20130657A/es unknown
- 2013-12-19 EC ECSP13013092 patent/ECSP13013092A/es unknown
- 2013-12-27 CO CO13301122A patent/CO6940375A2/es unknown
- 2013-12-30 MA MA36627A patent/MA35212B1/fr unknown
-
2016
- 2016-06-09 JP JP2016115175A patent/JP2016164578A/ja active Pending
- 2016-10-12 AU AU2016244254A patent/AU2016244254B2/en not_active Ceased
- 2016-12-01 US US15/366,986 patent/US20170269085A1/en not_active Abandoned
-
2017
- 2017-11-16 JP JP2017221000A patent/JP2018049033A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014523521A5 (enExample) | ||
| Koch et al. | Nanopore sequencing of DNA-barcoded probes for highly multiplexed detection of microRNA, proteins and small biomarkers | |
| Plebani et al. | SARS-CoV-2 serosurvey in health care workers of the Veneto Region | |
| McGill et al. | Serum mitochondrial biomarkers and damage‐associated molecular patterns are higher in acetaminophen overdose patients with poor outcome | |
| Darmanis et al. | Sensitive plasma protein analysis by microparticle-based proximity ligation assays | |
| NO20076656L (no) | Forbedrede immunoassay metoder | |
| JP2016538545A5 (enExample) | ||
| Roux et al. | Characteristics of donor-specific antibodies associated with antibody-mediated rejection in lung transplantation | |
| JP2018049033A (ja) | リシルオキシダーゼ様２のアッセイおよびその使用の方法 | |
| Panteghini et al. | Total error vs. measurement uncertainty: the match continues | |
| Morio et al. | Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury | |
| Erek-Toprak et al. | Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes | |
| Yan et al. | Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B | |
| Thrailkill et al. | Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens | |
| Kaur et al. | Defining target product profiles (TPPs) for aptamer-based diagnostics | |
| JP4272066B2 (ja) | Ｃａ１９−９の測定による敗血症の検出方法 | |
| Leli et al. | A prediction model for real-time PCR results in blood samples from febrile patients with suspected sepsis | |
| Enomoto et al. | An increased ratio of glycated albumin to HbA1c is associated with the degree of liver fibrosis in hepatitis B virus‐positive patients | |
| Cut et al. | Autopsy Findings and Inflammatory Markers in SARS-CoV-2: A Single-Center Experience | |
| Nomikou et al. | Soluble CD146, a novel endothelial marker, is related to the severity of liver disease | |
| US20250130237A1 (en) | Point of Care Assays | |
| Kwon et al. | Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma | |
| JP2009517381A5 (enExample) | ||
| CN102971630A (zh) | 非酒精性脂肪性肝炎检测和/或鉴别用标记物、检测和/或鉴别非酒精性脂肪性肝炎的方法及用于它们的试剂盒 | |
| JP6592627B1 (ja) | Ｎａｆｌｄ又はｎａｓｈの検出又はリスクの予測方法、ｎａｆｌｄ又はｎａｓｈを検出するための診断薬キット、対象における肝線維化の進行度の判定方法、及び対象における肝線維化の進行度を判定するための診断薬キット |